Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. Drug Safety: FDA Needs to Further Address Shortcomings in Its Postmarket Decision-making Process. GAO-07-599T. Washington, DC, 2007. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-599T.
Government Accountability Office. (2007, March 22). GAO-07-599T - Drug Safety: FDA Needs to Further Address Shortcomings in Its Postmarket Decision-making Process. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-599T
Government Accountability Office. GAO-07-599T - Drug Safety: FDA Needs to Further Address Shortcomings in Its Postmarket Decision-making Process. U.S. Government Printing Office, (22 Mar 2007), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-599T
Government Accountability Office, Drug Safety: FDA Needs to Further Address Shortcomings in Its Postmarket Decision-making Process, GovInfo, (March 22, 2007), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-599T